NO20024100L - In ovo beskyttelse mot infektios bronkitt - Google Patents

In ovo beskyttelse mot infektios bronkitt

Info

Publication number
NO20024100L
NO20024100L NO20024100A NO20024100A NO20024100L NO 20024100 L NO20024100 L NO 20024100L NO 20024100 A NO20024100 A NO 20024100A NO 20024100 A NO20024100 A NO 20024100A NO 20024100 L NO20024100 L NO 20024100L
Authority
NO
Norway
Prior art keywords
protection against
infectious bronchitis
against infectious
ovo
ovo protection
Prior art date
Application number
NO20024100A
Other languages
English (en)
Norwegian (no)
Other versions
NO20024100D0 (no
Inventor
Berend Jongsma
Frans G Davelaar
Marinus Wijnand Weststrate
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/775,750 external-priority patent/US20010046500A1/en
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20024100D0 publication Critical patent/NO20024100D0/no
Publication of NO20024100L publication Critical patent/NO20024100L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fodder In General (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Feed For Specific Animals (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20024100A 2000-02-29 2002-08-28 In ovo beskyttelse mot infektios bronkitt NO20024100L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51573200A 2000-02-29 2000-02-29
US09/775,750 US20010046500A1 (en) 2000-02-29 2001-02-02 In ovo protection against infectious bronchitis
PCT/US2001/004792 WO2001064244A2 (en) 2000-02-29 2001-02-15 In ovo protection against infectious bronchitis

Publications (2)

Publication Number Publication Date
NO20024100D0 NO20024100D0 (no) 2002-08-28
NO20024100L true NO20024100L (no) 2002-10-09

Family

ID=27058588

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024100A NO20024100L (no) 2000-02-29 2002-08-28 In ovo beskyttelse mot infektios bronkitt

Country Status (20)

Country Link
EP (2) EP1259257B1 (de)
JP (1) JP2003529565A (de)
CN (1) CN1406135A (de)
AR (1) AR027558A1 (de)
AT (1) ATE463253T1 (de)
AU (1) AU2001237016A1 (de)
BR (1) BR0108735A (de)
CA (1) CA2401145A1 (de)
CY (1) CY1110544T1 (de)
DE (1) DE60141743D1 (de)
DK (1) DK1259257T3 (de)
ES (1) ES2341841T3 (de)
IL (1) IL151039A0 (de)
MX (1) MXPA02008254A (de)
NO (1) NO20024100L (de)
NZ (1) NZ520761A (de)
PL (1) PL365447A1 (de)
PT (1) PT1259257E (de)
WO (1) WO2001064244A2 (de)
YU (1) YU65102A (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR031405A1 (es) 2000-11-21 2003-09-24 Wyeth Corp Metodos y vacunas para conferir proteccion in ovo contra la rinotraqueitis del pavo
SI1610817T1 (sl) 2003-03-03 2010-01-29 Intervet Int Bv Virus infekcijskega bronhitisa s spremenjenim spike genom
JPWO2007072916A1 (ja) * 2005-12-22 2009-06-04 財団法人化学及血清療法研究所 卵内接種用ワクチン
CN109641043A (zh) 2016-06-16 2019-04-16 勃林格殷格翰动物保健有限公司 针对感染性支气管炎病毒的疫苗
US11696947B2 (en) 2018-10-31 2023-07-11 Boehringer Ingelheim Vetmedica Gmbh H52 IBV vaccine with heterologous spike protein
AR116876A1 (es) 2018-10-31 2021-06-23 Boehringer Ingelheim Vetmedica Gmbh Vacuna de ibv 4/91 con proteína espicular heteróloga
CN114126645A (zh) 2019-05-10 2022-03-01 勃林格殷格翰动物保健有限公司 冠状病毒刺突蛋白的修饰的s1亚基
WO2020229257A1 (en) 2019-05-10 2020-11-19 Boehringer Ingelheim Vetmedica Gmbh Attenuated ibv with extended cell culture and tissue tropism
WO2020229249A1 (en) 2019-05-10 2020-11-19 Boehringer Ingelheim Vetmedica Gmbh Modified s2 subunit of the coronavirus spike protein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69426051T2 (de) * 1993-07-30 2001-05-10 Akzo Nobel N.V., Arnheim/Arnhem Impfstoff für Geflügel
US6506385B1 (en) * 1998-04-17 2003-01-14 Embrex, Inc. Live vaccines and methods of treatment therewith

Also Published As

Publication number Publication date
YU65102A (sh) 2005-09-19
CA2401145A1 (en) 2001-09-07
EP2198883A1 (de) 2010-06-23
ES2341841T3 (es) 2010-06-29
MXPA02008254A (es) 2003-02-06
AR027558A1 (es) 2003-04-02
DK1259257T3 (da) 2010-06-14
PL365447A1 (en) 2005-01-10
EP1259257A2 (de) 2002-11-27
WO2001064244A3 (en) 2002-01-31
AU2001237016A1 (en) 2001-09-12
IL151039A0 (en) 2003-04-10
BR0108735A (pt) 2002-12-17
PT1259257E (pt) 2010-06-01
CN1406135A (zh) 2003-03-26
NZ520761A (en) 2004-10-29
EP1259257B1 (de) 2010-04-07
DE60141743D1 (de) 2010-05-20
WO2001064244A2 (en) 2001-09-07
JP2003529565A (ja) 2003-10-07
NO20024100D0 (no) 2002-08-28
CY1110544T1 (el) 2015-04-29
ATE463253T1 (de) 2010-04-15

Similar Documents

Publication Publication Date Title
NO20031483D0 (no) Vaksine
DE60213127D1 (de) Durchschlagbeständige allzweckschutzgegenstände
NO20030823D0 (no) Vaksiner
DE60122331D1 (de) Schutzabdeckung
NO20024172D0 (no) Vaksine
NO20014323D0 (no) Vaksine
NO20031705L (no) Vaksiner
DE60128599D1 (de) Arbeitsgerät
DE60132401D1 (de) Tiefpassfilter
EE200200420A (et) Linesoliid - kristallivorm II
DE60002650D1 (de) Öladjuvierter Impfstoff
NO20030239L (no) Modifisert virus
DE10196135T1 (de) Port-Paket-Warteschlangenbildung
DE10196371T1 (de) Motor-Übertemperatur-Schutz
DK1132666T3 (da) Stövbeskyttelse
NO20011725D0 (no) Beskyttende emballeringsduk
NO20024100D0 (no) In ovo beskyttelse mot infektiös bronkitt
FR2806446B1 (fr) Turbocompresseur
NO20015752L (no) Individuelt beskyttelsesanordning, spesielt mot KBK-angrep
ATE281362T1 (de) Schützende verpackungseinheit
FR2806447B1 (fr) Turbocompresseur
NO992608L (no) Vaksine mot ILA-virus
DE50113022D1 (de) Seitenaufprallschutz
DE60101741D1 (de) Baumschutz
FI20002551A0 (fi) Voimalaite

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application